CrossrefInfokarte
Effectiveness and Tolerability of Anti-Tumor Necrosis Factor Alpha Therapy in Refractory Intestinal Behçet’s Disease: A Large Single-Center Study
Gut and Liver · 2026-03-15 · 20 (2) · 305-314
DOI: 10.5009/gnl250346 ↗Abstract
Kein Abstract verfügbar.
EUVIMED